Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 study. | Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 ...
Dole plc (NYSE:DOLE) Q4 2025 Earnings Call Transcript February 25, 2026 Dole plc beats earnings expectations. Reported EPS is ...
New AI capabilities drive smarter automation, enriched metadata, and assisted workflow design for live and file-based ...
The second forum of the University of Alberta Students’ Union (SU) 2026 elections was held at Campus Saint-Jean (CSJ) on ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する